OpenVSafe by OpenVAERS
Search V-safe

MZG-10992-24331

2 vaccinations 2 coded responses 19 check-ins 2 free-text entries 2 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
017 / MA
Registered
2022-10-07
Relationship
Child or adolescent in my care
Guardian
QWR-22096-20958
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-10-02
    Dose 1 — Moderna
  2. 2022-10-07
    Registered in v-safe
  3. 2022-10-07
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-10-08
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-10-09
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-10-16
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  7. 2022-10-23
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  8. 2022-10-30
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  9. 2022-11-04
    Dose 2 — Moderna
  10. 2022-11-06
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  11. 2022-11-07
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  12. 2022-11-08
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  13. 2022-11-09
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  14. 2022-11-10
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  15. 2022-11-11
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  16. 2022-11-18
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  17. 2022-11-25
    Survey response — day 21, dose 2, under 3
    MedDRA: Conjunctivitis — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Pink eye
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-11-25
    Report sent to call center — day 21, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  19. 2022-11-28
  20. 2022-12-02
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-12-09
    Survey response — day 35, dose 2, under 3
    MedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Diagnosed with RSV
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-12-09
    Report sent to call center — day 35, dose 2, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  23. 2022-12-12
  24. 2022-12-12
  25. 2022-12-16
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  26. 2023-02-03
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  27. 2023-05-07
    Health check-in — 6 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-10-02Moderna No
22022-11-04Moderna No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — day 21, dose 2, under 3

2022-11-25

Symptoms: Pink eye

Release 12 (Under 3) — day 35, dose 2, under 3

2022-12-09

Symptoms: Diagnosed with RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDConjunctivitis · · ✓
SDRespiratory syncytial virus infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…